Skip to main content
Bioera logo

Bioera — Investor Relations & Filings

Ticker · BIE ISIN · IT0005516130 LEI · 815600CE609AFE44D992 XMIL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2019-09-13 Declaration of Voting R…
Country IT Italy
Listing XMIL BIE

About Bioera

https://bioera.it/en/

Bioera S.p.A. is a company specializing in the production and distribution of natural and organic products. Its core business involves the development and marketing of a diverse portfolio that includes organic food, traditional food products, natural cosmetics, herbal remedies, and food supplements. The company focuses on providing consumers with products derived from natural sources, catering to the health and wellness market.

Recent filings

Filing Released Lang Actions
Bioera SpA - Assemblea Ordinaria e Straordinaria degli Azionisti del 13 settembre 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "COMUNICATO STAMPA" (Press Release) and details the resolutions passed during the "Assemblea Ordinaria e Straordinaria degli Azionisti" (Ordinary and Extraordinary Shareholders' Meeting) held on September 13, 2019. The resolutions cover the integration of the Board of Statutory Auditors, appointment of the Board of Directors, share grouping, capital reduction, and authorization for capital increases and warrant issuance. These actions are typical outcomes of a General Meeting. Since the document announces the results of shareholder votes on specific resolutions, the most appropriate classification is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not the AGM presentation itself (AGM-R), nor is it a general earnings release or a full annual report.
2019-09-13 Italian
Bioera SpA - Comunicato stampa del 12 settembre 2019
AGM Information Classification · 1% confidence The document is titled "COMUNICATO STAMPA" (Press Release) and discusses the failure of the ordinary and extraordinary shareholders' meeting to convene in the first call and the subsequent rescheduling for the second call. Crucially, it also announces a change in a proposed Board of Directors nomination (a director candidate withdrawing and a replacement being put forward). This content directly relates to corporate governance, board composition, and shareholder meetings. While it touches upon the AGM, the primary focus is the administrative update regarding the meeting's status and the board nomination change, which aligns best with Board/Management Information (MANG) or potentially Governance Information (CGR). Since the core event is the management/board change announcement stemming from the meeting context, MANG is a strong fit. However, the announcement of the meeting status itself (deserta assemblea) and the subsequent board nomination change are key components of corporate governance updates surrounding a general meeting. Given the specific focus on the Board of Directors nomination change, MANG is the most precise fit among the options, as it deals with senior management/board composition changes. It is not a full AGM presentation (AGM-R) or a proxy solicitation (PSI).
2019-09-12 Italian
Bioera SpA - Approvata la relazione finanziaria semestrale consolidata del Gruppo Bioera al 30 giugno 2019
Earnings Release Classification · 1% confidence The document is a press release from Bioera S.p.A. announcing the approval of its consolidated half-year financial report as of June 30, 2019. It provides a summary of key financial data (revenues, EBITDA, net result, net financial position) and management's commentary on business performance. While it contains substantive financial data, it is structured as a press release (Comunicato Stampa) summarizing the results rather than the full statutory interim report itself. According to the 'Menu vs Meal' rule, this is an announcement of the report, but because it contains significant financial data and analysis, it is best classified as an Earnings Release (ER) as it serves as the initial announcement of periodic financial results. H1 2019
2019-09-12 Italian
Bioera SpA - variazione calendario finanziario
Report Publication Announcement Classification · 1% confidence The document is a press release ("COMUNICATO STAMPA") from Bioera S.p.A. announcing a change in the schedule for the Board of Directors meeting intended to approve the semi-annual consolidated financial report for the period ending June 30, 2019. This is an announcement about the timing of a financial report release, not the report itself. According to Rule 2, if a document is short and announces the publication or timing of a report, it should be classified as a Report Publication Announcement (RPA). The document explicitly states the change in the date for the approval of the 'relazione finanziaria semestrale' (semi-annual financial report).
2019-09-10 Italian
Bioera SpA - assemblea ordinaria del 12/13 settembre 2019
AGM Information Classification · 1% confidence The document is a formal letter dated August 8, 2019, from an existing shareholder (Biofood Italia S.r.l.) to the company (Bioera S.p.A.). The core content is the proposal of a list of candidates for the Board of Directors ('LISTA DI CANDIDATI ALLA CARICA DI COMPONENTE DEL CONSIGLIO DI AMMINISTRAZIONE') to be voted upon at the upcoming Ordinary Shareholders' Meeting (AGM) scheduled for September 12/13, 2019. This document explicitly details the proposed directors, their qualifications (including independence), the proposed Chairman, and proposed remuneration. This is a key component of the process leading up to an Annual General Meeting (AGM) and relates directly to the composition of the board, which is often covered in proxy materials (DEF 14A) or AGM documentation. However, since it is a formal proposal of candidates by a shareholder for the AGM agenda, it most closely aligns with the materials presented or discussed during the AGM process. Given the options, 'AGM-R' (AGM Information) is the most appropriate fit as it concerns the slate of candidates for the board election at the AGM. It is not a DEF 14A (Remuneration Information) as the primary focus is the slate, not just compensation, nor is it a general Governance Report (CGR).
2019-08-22 Italian
Bioera SpA - Assemblea straordinaria del 12/13 settembre 2019
Capital/Financing Update Classification · 1% confidence The document is a detailed explanatory report ("Relazione illustrativa") from the Board of Directors of BIOERA S.P.A. regarding a specific proposal to be voted on at an upcoming Shareholders' Meeting ("Assemblea Ordinaria e Straordinaria"). The core subject matter detailed extensively throughout the text is the proposed issuance of Warrants (Warrant A and B) and the corresponding capital increases required to service these warrants, referencing specific Italian civil code articles (art. 2441, comma 6, cod. civ.) and CONSOB regulations. This document is not a general Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a meeting (like a Proxy Statement/DEF 14A). It is a formal, detailed report explaining a significant corporate action related to capital structure and financing, which aligns best with the 'Capital/Financing Update' category (CAP). While it is presented in the context of a shareholder meeting, its primary function is the detailed explanation of the capital operation itself, not just soliciting votes or announcing results.
2019-08-09 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.